[Current Status of Passive Immunization Against COVID in Respiratory Patients]. [PDF]
Mora Cuesta VM +2 more
europepmc +1 more source
[Failure of an anti-CGRP monoclonal antibody in the treatment of migraine. Is it worthwhile trying another one?] [PDF]
López-Moreno Y +3 more
europepmc +1 more source
Monoclonal Antibodies in Cancer Therapy: Mechanisms, Successes and Limitations. [PDF]
Coulson A, Levy A, Gossell-Williams M.
europepmc +1 more source
[Adaptation of headache units in Andalusia to the COVID-19 pandemic. Analysis of the Andalusian Neurology Society's Headache Study Group]. [PDF]
Lamas-Pérez R +5 more
europepmc +1 more source
[Successful Management of Wearing-off effect with Eptinezumab: Lessons from a case with Chronic Migraine Refractory to Two Subcutaneous CGRP Antibodies]. [PDF]
Polanco Fernández M +4 more
europepmc +1 more source
[Mild SARS-CoV-2 infection in vulnerable patients: implementation of a clinical pathway for early treatment]. [PDF]
Pinargote-Celorio H +13 more
europepmc +1 more source
Anticuerpos monoclonales en el tratamiento del cáncer
En la actualidad el cáncer es una patología muy prevalente, pero gracias al conocimiento de su biología se ha conseguido desarrollar nuevos fármacos, entre los que destacan los anticuerpos monoclonales (mabs). Estos son proteínas inmunitarias producidas por ingeniería genética, las cuales se van a unir a ciertas dianas presentes en la célula tumoral y ...
openaire +1 more source
Recommendations on vaccination in children and adolescents with inborn errors of immunity according to the expanded Colombian immunization program [PDF]
Cortés-Marín N +4 more
europepmc +1 more source
Reduction of plasma CGRP levels in migraine patients treated with erenumab or galcanezumab. [PDF]
García-Estévez DA +5 more
europepmc +1 more source
Effect of adding bemiparin and cefepime to routine treatment in cancer patients with SARS-CoV-2 infection. [PDF]
Doello K, Amezcua V.
europepmc +1 more source

